Prognostic implications of changes in cardiac troponin I levels in patients with non-ST elevation acute coronary syndrome

Biomarkers

Volumn 18, Issue 8, 2013, Pages 668-672

  Eggers, Kai M ^a   James, Stefan ^a   Venge, Per ^a   Lindahl, Bertil ^a  

^a UPPSALA UNIVERSITY   (Sweden)

Author keywords

Acute coronary syndrome; Cardiac troponin I; Cardiovascular events; Risk prediction

Indexed keywords

TROPONIN I;

AGED; ARTICLE; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY (TOPIC); NON ST SEGMENT ELEVATION ACUTE CORONARY SYNDROME; PREDICTIVE VALUE; PROGNOSIS; PROTEIN BLOOD LEVEL;

ACUTE CORONARY SYNDROME; AGED; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIUM; PROGNOSIS; PROSPECTIVE STUDIES; TROPONIN I;

EID: 84889798397     PISSN: 1354750X     EISSN: 13665804     Source Type: Journal    
DOI: 10.3109/1354750X.2013.843023     Document Type: Article

References (12)

1. Apple FS, Ler R, Murakami MA. (2012). Determination of 19 cardiac troponin I and T assay 99th percentile values from a common presumably healthy population. Clin Chem 58:1574-81
2. Giannitsis E, Steen H, Kurz K, et al. (2008). Cardiac magnetic resonance imaging study for quantification of infarct size comparing directly serial versus single time-point measurements of cardiac troponin T. J Am Coll Cardiol 51:307-14.
3. Hallén J. (2012). Troponin for the estimation of infarct size: What have we learned? Cardiology 121:204-12
4. Hassan AK, Bergheanu SC, Hasan-Ali H, et al. (2009). Usefulness of peak troponin-T to predict infarct size and long-term outcome in patients with first acute myocardial infarction after primary percutaneous coronary intervention. Am J Cardiol 103:779-84
5. Karavidas AJ, Vrachatis AD, Alpert MA, et al. (2002). Relation of troponin T release kinetics to long-term clinical outcome in patients with acute ST segment elevation myocardial infarction treated with a percutaneous intervention. Catheter Cardiovasc Interv 56:312-19
6. Kavsak PA, Ko DT, Wang X, et al. (2010). Increasing cardiac troponin changes measured by a research high-sensitivity troponin I assay: Absolute vs percentage changes and long-term outcomes in a chest pain cohort. Clin Chem 56:1902-4
7. Ottervanger JP, Armstrong P, Barnathan ES, et al. (2003). Long-term results after the glycoprotein IIb/IIIa inhibitor abciximab in unstable angina. One-year survival in the GUSTO IV-ACS (Global Use of Strategies To Open Occluded Coronary Arteries IV-Acute Coronary Sydrome) trial. Circulation 107:437-42
8. Pencina MJ, D'Agostino Sr RB, D'Agostino Jr RB, Vasan RS. (2008). Evaluating the added predictive ability of a new marker: From area under the ROC curve to reclassification and beyond. Stat Med 27: 157-72
9. Reichlin T, Twerenbold R, Maushart C, et al. (2013). Risk stratification in patients with unstable angina using absolute serial changes of 3 high-sensitive troponin assays. Am Heart J 165:371-8.e3
10. Simoons ML, GUSTO IV-ACS Investigators. (2001). Effect of glycoprotein IIb/IIIa receptor blocker abciximab on outcome in patients with acute coronary syndromes without early revascularisation: The GUSTO IV-ACS randomised trial. Lancet 357:1915-24
11. Tarantini G, Razzolini R, Cacciavillani L, et al. (2006). Influence of transmurality, infarct size, and severe microvascular obstruction on left ventricular remodeling and function after primary coronary angioplasty. Am J Cardiol 98:1033-40
12. Thygesen K, Alpert JS, Jaffe AS, et al. (2012). Third universal definition of myocardial infarction. Circulation 126:2020-35.